Parmax Pharma Limited

Parmax Pharma Limited Share · INE240T01014 (XBOM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Parmax Pharma Limited
No Price
Closing Price XBOM 30.04.2026: 30,00 INR
30.04.2026 09:58
Current Prices from Parmax Pharma Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XBOM: MSE
MSE
PARMAX.BO
INR
30.04.2026 09:58
30,00 INR
-
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 3,74 M
Company Profile for Parmax Pharma Limited Share
Parmax Pharma Ltd. engages in the manufacture of bulk drugs like ampicilin, amoxycillin, cephalexin, and nalidixic acid. The company also plans to extend its activities in formulation of tablets, capsules, ointments, & injectable. The company was founded on November 2, 1994 and is headquartered in Rajkot, India.

Company Data

Name Parmax Pharma Limited
Company Parmax Pharma Limited
Website https://www.parmaxpharma.com
Primary Exchange XBOM MSE
ISIN INE240T01014
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Umang Alkesh Gosalia
Market Capitalization 112 Mio
Country India
Currency INR
Employees -
Address Plot No. 20, Survey No. 52, Rajkot

Ticker Symbols

Name Symbol
MSE PARMAX.BO
More Shares
Investors who hold Parmax Pharma Limited also have the following shares in their portfolio:
G Capital Public Company Limited
G Capital Public Company Limited Share
JINGRUI 21/23 REGS
JINGRUI 21/23 REGS Bond